U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
OBLIMERSEN
85J5ZP6YSL
Possibly Marketed Outside US
General
Record Details
Names
7
Classification
8
Identifiers
13
Subunits
1
Sugars
1
Linkages
1
Relationships
1
Active Moiety
1
OBLIMERSEN
85J5ZP6YSL
Possibly Marketed Outside US
General
Approval Year
Unknown
149,124
Record Details
Substance Class
Nucleic Acid
Sequence Type
P0LYNUCLEOTIDE
Record UNII
85J5ZP6YSL
Record Status
Validated (UNII)
Record Version
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
7
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
OBLIMERSEN
Official Name
English
D(P-THIO)(T-C-T-C-C-C-A-G-C-G-T-G-C-G-C-C-A-T)DNA
Preferred Name
English
OBLIMERSEN [EMA EPAR]
Common Name
English
OBLIMERSEN [MI]
Common Name
English
oblimersen [INN]
Common Name
English
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Classification
8
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Other antineoplastic agents
ATC
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
Other antineoplastic agents
oblimersen
WHO-ATC
L01XX36
Designated
ORPHAN DRUG
Designated
Treatment of chronic lymphocytic leukemia
FDA ORPHAN DRUG
145501
Other antineoplastic agents
VATC
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
Other antineoplastic agents
oblimersen
WHO-VATC
QL01XX36
Designated
ORPHAN DRUG
Designated
Treatment of advanced malignant melanoma (Stages II,III, IV).
FDA ORPHAN DRUG
134600
NEVI AND MELANOMAS
EMA EPAR
DISEASES
CANCER
NEOPLASMSBY HOLISTIC TYPE
NEVI AND MELANOMAS
MELANOMA
EMA ASSESSMENT REPORTS
GENASENSE (REFUSED: MELANOMA)
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Identifiers
13
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
CAS
190977-41-4
PRIMARY
ChEMBL
CHEMBL2108324
PRIMARY
MESH
C408162
PRIMARY
NCI_THESAURUS
C1870
PRIMARY
DRUG BANK
DB13811
PRIMARY
Showing 1 to 5 of 13 entries
Previous
1
2
3
Next
Subunits
1
Sugars
1
Show
5
20
100
All
entries
Sugar
Site Range
Site Count
Sugar
Site Range
Site Count
Deoxyribose (DNA)
1_1-1_18
18 / 18
Showing 1 to 1 of 1 entries
Previous
1
Next
Linkages
1
Show
5
20
100
All
entries
Linkage
Site Range
Site Count
Linkage
Site Range
Site Count
Phosporothioate
1_2-1_18
17 / 17
Showing 1 to 1 of 1 entries
Previous
1
Next
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
SH55B0RQ9K
OBLIMERSEN SODIUM
SALT/SOLVATE -> PARENT
Showing 1 to 1 of 1 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
85J5ZP6YSL
OBLIMERSEN
ACTIVE MOIETY
Showing 1 to 1 of 1 entries
Previous
1
Next
